Table 2.
Comparison of insulin resistance, glucose (FBG, FINS, and HbA1c) and bone metabolism (Ca, P, calcium, and phosphorus production, iPTH, BALP, and IGF-1) indexes between male and female.
| Male | Female | p-value | |
|---|---|---|---|
| 25(OH)D (ng/mL)a | 20.27 ± 11.43 | 22.10 ± 8.97 | 0.364 |
| HOMA-IRa | 5.79 ± 2.17 | 5.54 ± 1.90 | 0.562 |
| HbA1c (%) | 10.03 ± 3.02 | 8.82 ± 2.34 | <0.05 |
| FINS (pmol/L)a | 135.26 ± 76.02 | 115.90 ± 57.21 | 0.144 |
| FBG (mmol/L)a | 7.98 ± 3.76 | 8.36 ± 2.69 | 0.545 |
| iPTH (pg/mL)a | 40.31 ± 14.47 | 46.40 ± 13.42 | <0.05 |
| Ca (mmol/L)a | 2.29 ± 0.14 | 2.36 ± 0.12 | <0.05 |
| P (mmol/L)a | 1.35 ± 0.15 | 1.37 ± 0.13 | 0.536 |
| Calcium phosphorus production [(mg/dL)2]a | 38.47 ± 5.17 | 40.18 ± 4.93 | 0.083 |
| BALP (u/L)a | 184.84 ± 13.96 | 184.57 ± 15.85 | 0.927 |
| IGF-1 (pg/mL)a | 252.45 ± 138.43 | 306.28 ± 152.06 | 0.056 |
a
Mean ± SD. HOMA-IR, homeostatic model estimates of insulin resistance; 25(OH)D, 25-hydroxy vitamin D; Ca, serum calcium; P, serum phosphorus; FINS, fasting blood insulin; HbA1c, glycated hemoglobin A1c; iPTH, intact parathyroid hormone; BALP, bone alkaline phosphatase; IGF-1, insulin-like growth factor-1.